- Home
- RPRX vs BG Comparison
RPRX vs BG Comparison
Compare RPRX & BG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | BG |
|---|---|---|
| Founded | 1996 | 1818 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 21.8B |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | RPRX | BG |
|---|---|---|
| Price | $57.62 | $103.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $65.38 | ★ $141.78 |
| AVG Volume (30 Days) | ★ 2.6M | 1.7M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | 1.65% | ★ 2.80% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.71 | 0.35 |
| Revenue | $2,378,193,000.00 | ★ $70,329,000,000.00 |
| Revenue This Year | $47.38 | $30.44 |
| Revenue Next Year | $8.97 | $2.72 |
| P/E Ratio | ★ $80.20 | $294.86 |
| Revenue Growth | 5.06 | ★ 32.43 |
| 52 Week Low | $35.50 | $79.12 |
| 52 Week High | $64.38 | $134.87 |
Technical Indicators
Market Signals| Indicator | RPRX | BG |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 34.26 |
| Support Level | $56.36 | N/A |
| Resistance Level | $58.84 | $126.62 |
| Average True Range (ATR) | 1.07 | 2.69 |
| MACD | -0.05 | -0.55 |
| Stochastic Oscillator | 61.31 | 9.34 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About BG Bunge Limited
Bunge Global SA is an agribusiness solutions company, connecting farmers to consumers and delivering essential food, feed and fuel to the globe. The company segments include Soybean Processing and Refining; Softseed Processing and Refining; Other Oilseeds Processing and Refining; Grain Merchandising and Milling; and Corporate and Other. It generates maximum revenue from the Soybean Processing and Refining segment, which includes integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybeans and soybean related products, as well as biodiesel and fertilizer production and distribution. Geographically, the company operates in United States, Switzerland, Netherlands, and Rest of the World.